Synthesis and antimycobacterial activity of 2,1′-dihydropyridomycins

ACS Medicinal Chemistry Letters

Volumn 4, Issue 2, 2013, Pages 264-268

  Horlacher, Oliver P ^a   Hartkoorn, Ruben C ^b   Cole, Stewart T ^b   Altmann, Karl Heinz ^a  

^a ETH ZURICH   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

InhA; natural products; pyridomycin; total synthesis; tuberculosis

Indexed keywords

2,1' DIHYDROPYRIDOMYCIN DERIVATIVE; ANTIINFECTIVE AGENT; ISOVALERIC ACID; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CYCLIZATION; DIHYDROXYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 84873963450     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300385q     Document Type: Article

References (22)

1. Glaziou, P.; Floyd, K.; Raviglione, M. Global Burden and Epidemiology of Tuberculosis Clin. Chest Med. 2009, 30, 621-636
2. Cegielski, J. P. Extensively Drug-Resistant Tuberculosis: "There Must Be Some Kind of Way Out of Here" Clin. Infect. Dis. 2010, 50, 195-200
3. Maeda, K.; Kosaka, H.; Okami, Y.; Umezawa, H. A New Antibiotic, Pyridomycin J. Antibiot., Ser. A 1953, 6, 140
4. The structure and absolute configuration of 1 were first reported in 1967: Koyama, G.; Iitaka, Y.; Maeda, K.; Umezawa, H. Structure of Pyridomycin Tetrahedron Lett. 1967, 37, 3587-3590. Note that the structural drawing of 1 in this paper depicts a R configuration for both C9 and C10. In contrast, the drawing of the X-ray structure of the molecule in Figure 1 of the same paper shows these chiral centers to be present in a S, S configuration. As in the new analogues 2 and 3 that are reported here for the first time, C9 and C10 were both S -configured in the synthetic pyridomycin reported by Kinoshita et al. (ref 9); the synthetic material was found to be identical spectroscopically with natural pyridomycin
5. Kuroya, M.; Takahashi, B.; Hinuma, Y.; Yashima, T.; Watanabe, K.; Hamada, S. An Antituberculous Antibiotic from Streptomyces sp. Studies on the Streptomyces Antibiotics. XXXII J. Antibiot., Ser. A 1954, 7, 58-59
6. Hartkoorn, R. C.; Sala, C.; Neres, J.; Pojer, F.; Magnet, S.; Mukherjee, R.; Uplekar, S.; Boy-Rottger, S.; Altmann, K.-H.; Cole, S. T. Towards a New Tuberculosis Drug: Pyridomycin-Nature's Isoniazid EMBO Mol. Med. 2012, 4, 1032-1042
7. Banerjee, A.; Dubnau, E.; Quemard, A.; Balasubramanian, V.; Um, K. S.; Wilson, T.; Collins, D.; de Lisle, G.; Jacobs, W. R., Jr. InhA, a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium Tuberculosis Science 1994, 263, 227-230
8. Vilcheze, C.; Wang, F.; Arai, M.; Hazbon, M. H.; Colangeli, R.; Kremer, L.; Weisbrod, T. R.; Alland, D.; Sacchettini, J. C.; Jacobs, W. R., Jr. Transfer of a Point Mutation in Mycobacterium Tuberculosis InhA Resolves the Target of Isoniazid Nat. Med. 2006, 12, 1027-1029
9. Kinoshita, M.; Nakata, M.; Takarada, K.; Tatsuta, K. Total Synthesis of Pyridomycin Tetrahedron Lett. 1989, 30, 7419-7422
10. Apart from the problem of controlling double bond geometry, even the introduction of the C2-C1′ double bond as such proved to be difficult and could not be accomplished with high efficiency. See also Kinoshita, M.; Mori, Y. Bull. Soc. Chem. Jpn. 1985, 58, 3298-3308
11. Abiko, A.; Liu, J.-F; Masamune, S. The Anti-Selective Boron-Mediated Asymmetric Aldol Reaction of Carboxylic Esters J. Am. Chem. Soc. 1997, 119, 2586-2587
12. 2 Mediated Addition of Allylic Halides or Phosphates to N-Protected Alpha-Amino Aldehydes. Stereocontrolled Synthesis of a New Core for C-2 Symmetric HIV-protease Inhibitors Tetrahedron 1996, 52, 7379-7390
13. Humphrey, C. E.; Furegati, M.; Laumen, K.; La Vecchia, L.; Leutert, T.; Müller-Hartwieg, J. C. D.; Vögtle, M. Optimized Synthesis of l -m-Tyrosine Suitable for Chemical Scale-up Org. Process Res. Dev. 2007, 11, 1069-1075
14. Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J. Alpha-Amino-Acids by Catalytic Asymmetric Hydrogenation J. Mol. Catal. 1983, 19, 159-69
15. Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman, G. L.; Weinkauff, D. J. Asymmetric Hydrogenation-Rhodium Chiral Bisphosphine Catalyst J. Am. Chem. Soc. 1977, 99, 5946-5952
16. 4, see Bozell, J. J.; Vogt, C. E.; Gozum, J. Transition-Metal- Assisted Asymmetric-Synthesis of Amino-Acid-Analogs-A New Synthesis of Optically Pure d -Pyridylalanine and l -Pyridylalanine J. Org. Chem. 1991, 56, 2584-2587
17. Krause, H. W.; Foken, H.; Pracejus, H. Aminophosphine Phosphinites of Propranolol as Ligands for Rhodium Catalyzed Asymmetric Hydrogenation of Dehydroamino Acids New J. Chem. 1989, 13, 615-620
18. Dobler, C.; Kreuzfeld, H. J.; Michalik, M.; Krause, H. W. Unusual Amino Acids. 7. Asymmetric Synthesis of 3- and 4-Pyridylalanines Tetrahedron: Asymmetry 1996, 7, 117-125
19. Dess, D. B.; Martin, J. C. Readily Accessible 12-I-5 Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones J. Org. Chem. 1983, 48, 4155-4156
20. Dale, J. A.; Dull, D. L.; Mosher, H. S. α-Methoxy-α- Trifluoromethylphenylacetic Acid, a Versatile Reagent for the Determination of Enantiomeric Composition of Alcohols and Amines J. Org. Chem. 1969, 34, 2543-2549
21. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K. S.; Kwong, H. L.; Morikawa, K.; Wang, Z. M.; Xu, D.; Zhang, X.-L. The Osmium-catalyzed Asymmetric Dihydroxylation: A New Ligand Class and a Process Improvement J. Org. Chem. 1992, 57, 2768-2771
22. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Rapid Esterification by Means of Mixed Anhydride and Its Application to Large-Ring Lactonization Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993